Identification of FDA-Approved Drugs and Bioactives that Protect Hair Cells in the Zebrafish (Danio rerio) Lateral Line and Mouse (Mus musculus) Utricle

被引:0
作者
Henry C. Ou
Lisa L. Cunningham
Shimon P. Francis
Carlene S. Brandon
Julian A. Simon
David W. Raible
Edwin W Rubel
机构
[1] University of Washington,Virginia Merrill Bloedel Hearing Research Center
[2] University of Washington,Department of Otolaryngology
[3] University of Washington,Head and Neck Surgery
[4] Seattle Children’s,Department of Biological Structure
[5] Medical University of South Carolina,Department of Pathology and Laboratory Medicine
[6] Fred Hutchinson Cancer Research Center,undefined
来源
Journal of the Association for Research in Otolaryngology | 2009年 / 10卷
关键词
FDA library; zebrafish; hair cell; protection; ototoxicity; aminoglycoside;
D O I
暂无
中图分类号
学科分类号
摘要
The hair cells of the larval zebrafish lateral line provide a useful preparation in which to study hair cell death and to screen for genes and small molecules that modulate hair cell toxicity. We recently reported preliminary results from screening a small-molecule library for compounds that inhibit aminoglycoside-induced hair cell death. To potentially reduce the time required for development of drugs and drug combinations that can be clinically useful, we screened a library of 1,040 FDA-approved drugs and bioactive compounds (NINDS Custom Collection II). Seven compounds that protect against neomycin-induced hair cell death were identified. Four of the seven drugs inhibited aminoglycoside uptake, based on Texas-Red-conjugated gentamicin uptake. The activities of two of the remaining three drugs were evaluated using an in vitro adult mouse utricle preparation. One drug, 9-amino-1,2,3,4-tetrahydroacridine (tacrine) demonstrated conserved protective effects in the mouse utricle. These results demonstrate that the zebrafish lateral line can be used to screen successfully for drugs within a library of FDA-approved drugs and bioactives that inhibit hair cell death in the mammalian inner ear and identify tacrine as a promising protective drug for future studies.
引用
收藏
页码:191 / 203
页数:12
相关论文
共 246 条
[1]  
Bodur E(2001)Tezcan EF. Inhibition effects of benactyzine and drofenine on human serum butyrylcholinesterase Arch. Biochem. Biophys 386 25-29
[2]  
Cokugras AN(2007)Prevention of noise- and drug-induced hearing loss with D-methionine Hear. Res 226 92-103
[3]  
Campbell KC(2008)Using the zebrafish lateral line to screen for ototoxicity J. Assoc. Res. Otolaryngol 9 178-190
[4]  
Meech RP(1992)Comparison of the blood-brain barrier and liver penetration of acridine antitumor drugs Cancer. Chemother. Pharmacol 29 439-444
[5]  
Klemens JJ(2002)Caspase activation in hair cells of the mouse utricle exposed to neomycin J. Neurosci 22 8532-8540
[6]  
Gerberi MT(1992)Assessment of uncoupling by amiloride analogs Biochemistry 31 8055-8058
[7]  
Dyrstad SS(1988)Calbindin (CaBP 28 kDa) localization in the peripheral vestibular system of various vertebrates Hear. Res.L 33 273-278
[8]  
Larsen DL(1986)Specific binding of 3H-nicergoline in rat brain: comparison with the selective alpha 1-antagonist 3H-prazosin J. Pharmacol 17 65-74
[9]  
Mitchell DL(1987) 9-Amino-1,2,3,4-tetrahydroacridine (THA), an alleged drug for the treatment of Alzheimer's disease, inhibits acetylcholinesterase activity and slow outward K+ current Eur. J. Pharmacol 141 153-157
[10]  
El-Azizi M(2004)PET Studies on P-glycoprotein function in the blood-brain barrier: how it affects uptake and binding of drugs within the CNS Curr. Pharm. Des 10 1493-1503